Centessa Pharmaceuticals PLC (CNTA)
18.19
+1.45
(+8.66%)
USD |
NASDAQ |
Nov 21, 16:00
18.18
-0.02
(-0.08%)
After-Hours: 20:00
Centessa Pharmaceuticals Enterprise Value: 1.764B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.764B |
| November 19, 2024 | 1.776B |
| November 18, 2024 | 1.680B |
| November 15, 2024 | 1.667B |
| November 14, 2024 | 1.865B |
| November 13, 2024 | 1.941B |
| November 12, 2024 | 1.799B |
| November 11, 2024 | 1.763B |
| November 08, 2024 | 1.733B |
| November 07, 2024 | 1.685B |
| November 06, 2024 | 1.665B |
| November 05, 2024 | 1.667B |
| November 04, 2024 | 1.652B |
| November 01, 2024 | 1.623B |
| October 31, 2024 | 1.537B |
| October 30, 2024 | 1.544B |
| October 29, 2024 | 1.590B |
| October 28, 2024 | 1.599B |
| October 25, 2024 | 1.598B |
| October 24, 2024 | 1.598B |
| October 23, 2024 | 1.552B |
| October 22, 2024 | 1.593B |
| October 21, 2024 | 1.636B |
| October 18, 2024 | 1.670B |
| October 17, 2024 | 1.639B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.702B |
| October 15, 2024 | 1.676B |
| October 14, 2024 | 1.751B |
| October 11, 2024 | 1.662B |
| October 10, 2024 | 1.619B |
| October 09, 2024 | 1.603B |
| October 08, 2024 | 1.674B |
| October 07, 2024 | 1.599B |
| October 04, 2024 | 1.656B |
| October 03, 2024 | 1.648B |
| October 02, 2024 | 1.698B |
| October 01, 2024 | 1.822B |
| September 30, 2024 | 1.662B |
| September 27, 2024 | 1.812B |
| September 26, 2024 | 1.796B |
| September 25, 2024 | 1.754B |
| September 24, 2024 | 1.777B |
| September 23, 2024 | 1.783B |
| September 20, 2024 | 1.913B |
| September 19, 2024 | 1.819B |
| September 18, 2024 | 1.801B |
| September 17, 2024 | 1.875B |
| September 16, 2024 | 1.898B |
| September 13, 2024 | 1.707B |
| September 12, 2024 | 1.493B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-170.61M
Minimum
Jun 06 2022
2.256B
Maximum
Jun 17 2021
572.54M
Average
440.22M
Median
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals PLC | -3.674M |
| Verona Pharma PLC | 2.963B |
| Autolus Therapeutics PLC | 88.07M |
| Mereo BioPharma Group PLC | 480.45M |
| Achilles Therapeutics PLC | -42.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -42.57M |
| Total Expenses (Quarterly) | 46.40M |
| EPS Diluted (Quarterly) | -0.37 |
| Earnings Yield | -8.36% |